corticosterone has been researched along with Tauopathies in 2 studies
Tauopathies: Neurodegenerative disorders involving deposition of abnormal tau protein isoforms (TAU PROTEINS) in neurons and glial cells in the brain. Pathological aggregations of tau proteins are associated with mutation of the tau gene on chromosome 17 in patients with ALZHEIMER DISEASE; DEMENTIA; PARKINSONIAN DISORDERS; progressive supranuclear palsy (SUPRANUCLEAR PALSY, PROGRESSIVE); and corticobasal degeneration.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Di Pietro, O | 1 |
Pérez-Areales, FJ | 1 |
Juárez-Jiménez, J | 1 |
Espargaró, A | 1 |
Clos, MV | 1 |
Pérez, B | 1 |
Lavilla, R | 1 |
Sabaté, R | 1 |
Luque, FJ | 1 |
Muñoz-Torrero, D | 1 |
Lejavova, K | 1 |
Ondicova, K | 1 |
Horvathova, L | 1 |
Hegedusova, N | 1 |
Cubinkova, V | 1 |
Vargovic, P | 1 |
Manz, G | 1 |
Filipcik, P | 1 |
Mravec, B | 1 |
Novak, M | 1 |
Kvetnansky, R | 1 |
2 other studies available for corticosterone and Tauopathies
Article | Year |
---|---|
Tetrahydrobenzo[h][1,6]naphthyridine-6-chlorotacrine hybrids as a new family of anti-Alzheimer agents targeting β-amyloid, tau, and cholinesterase pathologies.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Cholinesterase Inhibitors; Cholinesterases; Dose-Response | 2014 |
Stress-induced activation of the sympathoadrenal system is determined by genetic background in rat models of tauopathy.
Topics: Animals; Corticosterone; Disease Models, Animal; Epinephrine; Genetic Predisposition to Disease; Nor | 2015 |